Thu, 18th Apr 2019 11:52
LONDON (Alliance News) - Synairgen PLC on Thursday said Non-Executive Director Paul Clegg will retire from the company's board after the company's annual general meeting on June 3.
Iain Buchanan, non-executive director, will take on the chairmanship of the remuneration committee from the same date, the respiratory drug discovery company said.
Synairgen shares were trading down 3.7% at 13.00 pence each on Thursday.
Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints ...
(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.
(Alliance News) - Synairgen PLC on Tuesday promoted Marcin Mankowski to chief medical officer, effective immediately.
Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Pretax lo...
Synairgen (SNG)